Back to Healthcare Services
    Healthcare Services

    Sell Your Veterinary Practice

    Veterinary medicine has become one of the most active M&A markets in healthcare. National platforms, PE-backed consolidators, and specialty groups are acquiring companion animal practices at record pace, driven by growing pet ownership, recession-resistant demand, and the structural advantages of multi-location veterinary networks. Multiples for practices with $1M+ EBITDA now range from 8x to 13x, with partnership and retained equity structures giving selling veterinarians exposure to future platform value.

    FISART advises veterinary practice owners on sell-side processes designed for how today's buyers actually evaluate and price these businesses. The difference between an average exit and a premium outcome is not revenue alone. It is associate depth, transition readiness, facility quality, and positioning your practice so that multiple qualified buyers compete seriously for it.

    Schedule a Confidential Consultation

    8-13x EBITDA

    150+ active buyers

    5-8 months

    36,000+ practices

    Why Veterinary M&A Has Accelerated

    The veterinary industry is in the middle of a corporatization wave that has transformed practice ownership. Over the past decade, corporate-backed platforms have acquired thousands of independent hospitals, and the pace is increasing. The fundamental economics driving this consolidation are straightforward: pet ownership is at all-time highs, veterinary spending per household grows 6-8% annually, and companion animal healthcare demand is largely insensitive to economic cycles.

    For buyers, veterinary practices offer what few healthcare verticals can match: recurring patient relationships that span 10-15 years per pet, a growing consumer willingness to spend on advanced diagnostics and treatments, and a services model that does not face the reimbursement pressures of human healthcare. The result is a buyer market with substantial available capital chasing a declining pool of independent practices.

    What has changed most recently is deal structure. Five years ago, most veterinary transactions were straightforward buyouts. Today, partnership and joint venture models dominate, with buyers offering sellers 20-40% retained equity stakes alongside upfront cash. This structure aligns interests during the transition and gives selling veterinarians a second financial event when the platform eventually trades to a new owner at a higher multiple. Understanding these structures and their real economic implications is critical for any veterinarian considering a sale.

    Timing matters because consolidation is compressing the pool of high-quality independent practices. As platforms grow, they become more selective about which practices they acquire and at what multiples. Owners who sell while buyer competition is high capture better terms, higher upfront cash percentages, and more favorable partnership structures than those who wait until their market is saturated with corporate-owned hospitals.

    What Buyers Evaluate

    • Revenue per DVM and associate productivity
    • Owner clinical dependency and transition readiness
    • Patient visit volume and retention rates
    • Payor mix: wellness plans vs. fee-for-service
    • Facility condition, equipment age, and lease terms
    • Staff retention, technician tenure, and hiring pipeline

    Who Buys Veterinary Practices

    The veterinary buyer universe is deep and well-capitalized, spanning national platforms with thousands of hospitals, PE-backed regional consolidators, specialty groups, and long-term family office capital. Each buyer type has distinct acquisition criteria and deal structure preferences.

    National veterinary platforms

    Mars Veterinary Health, National Veterinary Associates (NVA), and VetCor operate thousands of hospitals and actively acquire single and multi-location practices. They focus on companion animal clinics with strong associate teams, predictable case volume, and well-maintained facilities in markets where they want geographic density.

    PE-backed regional consolidators

    Mid-market private equity firms back veterinary roll-ups that target 5-15 practice acquisitions per year in specific regions. They prioritize practices with $1M+ EBITDA, stable associate coverage, and operational consistency that makes integration straightforward. Many offer partnership structures to retain selling veterinarians.

    Specialty and emergency hospital groups

    Platforms focused on emergency, critical care, and specialty veterinary medicine acquire practices with referral relationships and after-hours capabilities. They value practices that serve as referral destinations or can be converted into multi-specialty facilities within their existing network.

    Family offices and independent sponsors

    Long-term capital sources attracted to veterinary medicine's recession-resistant demand, repeat visit patterns, and growing pet ownership trends. They often partner with experienced veterinary operators to form new platforms, offering flexible deal structures including partnership and retained equity arrangements.

    What Your Veterinary Practice Is Really Worth

    Veterinary practice valuations range from 8x to 13x EBITDA for practices with $1M+ in adjusted earnings. The spread is driven by a few specific factors. Practices with strong associate teams, minimal owner clinical dependency, and consistent patient volumes trade at the upper end. Single-DVM practices where the owner produces 60%+ of revenue trade at the lower end, typically with earnout structures that tie a portion of the purchase price to post-close retention metrics.

    Scale matters significantly. Practices with $1M-$3M EBITDA typically see 9.5-11.5x multiples, while those above $3M can reach 11-13x because they are large enough to serve as platform anchors for PE-backed consolidators. Below $1M EBITDA, multiples compress to 8-9.5x and deal structures include more contingent components. Multi-location groups consistently command premiums over single-location practices because they offer buyers immediate scale and operational consistency.

    One critical dynamic that many veterinary sellers overlook: only 60-80% of the headline multiple typically lands as cash at closing. The remainder consists of rollover equity, earnouts, and sometimes seller notes. A practice quoted at 10x EBITDA may deliver 7x in day-one cash with 2x in rollover equity and 1x in an earnout tied to 18-month production benchmarks. FISART ensures owners evaluate the full economic package, not just the headline number, so the final deal structure aligns with their financial goals and risk tolerance.

    Valuation Drivers

    • Revenue per DVM and associate productivity
    • Owner clinical dependency and transition readiness
    • Patient visit volume and retention rates
    • Payor mix: wellness plans vs. fee-for-service
    • Facility condition, equipment age, and lease terms
    • Staff retention, technician tenure, and hiring pipeline

    Which Segments Are in Highest Demand

    Buyer appetite varies by practice type. General companion animal practices remain the highest-volume acquisition target, while emergency, specialty, and multi-location groups command the strongest multiples.

    General companion animal practices
    Emergency and specialty veterinary hospitals
    Multi-location veterinary groups
    Mixed animal and large animal practices
    Veterinary urgent care clinics
    Mobile and house-call veterinary services

    When Selling Makes Sense for You

    FISART works with veterinary practice owners who want a structured, professionally managed transaction. Whether you are exploring a full sale, a partnership model with retained equity, or simply want to understand how buyers would evaluate your practice today, the starting point is an honest assessment of where your practice stands and what steps would materially strengthen its position before going to market.

    We work with businesses that

    • Your practice generates $1M+ in annual EBITDA
    • You have at least two associate veterinarians on staff
    • You are considering a full sale, partnership, or retained equity structure
    • Your facility is in good condition with a transferable lease
    • You want clarity on what corporatization means for your practice and team

    Frequently Asked Questions

    Straight answers on valuation, deal structure, and process.

    Veterinary practice valuations currently range from 8x to 13x EBITDA for practices with $1M+ in adjusted earnings, though the range widens based on scale and model. Single-location general practices typically trade at 8-9.5x EBITDA, while multi-location groups and specialty hospitals can reach 11-13x. The key valuation drivers are associate depth (how much production continues without the owner), revenue per DVM, patient retention rates, facility condition, and geographic market attractiveness. Practices in underserved or high-growth pet ownership areas command premiums because buyers face less competition for acquisitions and stronger organic growth potential. FISART builds a normalized EBITDA analysis that adjusts for owner compensation, discretionary expenses, and one-time costs so buyers see an accurate picture of the practice's earning power.

    Corporatization means selling to a platform buyer that will handle business operations (billing, HR, procurement, marketing) while you and your team continue practicing medicine. The clinical autonomy you retain depends on the specific buyer and deal terms. Most corporate veterinary groups position themselves as partners to their veterinarians, maintaining clinical independence while centralizing the administrative functions that consume owner time. Staff typically keep their positions and often receive improved benefits packages, continuing education budgets, and career advancement paths within a larger organization. The primary change is that business decisions move to the platform level. FISART helps owners evaluate which buyers offer the best combination of clinical autonomy, team continuity, and financial terms for their specific situation.

    Partnership and joint venture structures have become increasingly common in veterinary M&A, particularly among PE-backed consolidators. In a typical arrangement, the buyer acquires 60-80% of the practice while the selling veterinarian retains 20-40% ownership. The retained equity gives you ongoing income from the practice plus exposure to future value creation as the broader platform grows and eventually sells to another buyer at a higher multiple. This second-bite-of-the-apple dynamic can be significant: veterinarians who retained 20-30% equity at 8x multiples have seen their retained stakes increase substantially when the platform sold at 12-14x a few years later. FISART structures these arrangements so that retained equity terms, governance rights, distribution schedules, and exit triggers are clearly documented and aligned with your financial and professional goals.

    In veterinary transactions, only 60-80% of the headline purchase price typically lands as cash at closing. The remainder comes through rollover equity (15-30%), earnouts (5-15%), and sometimes seller notes. The exact split depends on practice size, buyer type, and deal structure. National platforms like Mars Veterinary Health tend to pay a higher proportion in cash upfront because they are not relying on PE fund structures that require equity rollover. PE-backed consolidators typically require 20-30% rollover equity as part of their fund economics and alignment incentives. Earnouts are common when there is transition risk, production concentration in the selling veterinarian, or when the buyer wants to bridge a gap between what they will pay unconditionally and what the seller expects. FISART ensures owners understand the true economic value of each component before signing.

    Well-prepared veterinary transactions typically close within 5-8 months from process launch. The timeline includes 3-5 weeks of preparation (financial normalization, operational documentation, lease review), 6-8 weeks of buyer outreach and offer collection, and 10-14 weeks of diligence through closing. Veterinary deals move at moderate speed compared to other healthcare verticals because buyers have standardized evaluation frameworks for practice economics. Delays usually stem from unresolved lease assignments, associate recruitment needs to fill gaps before closing, equipment or facility issues discovered during diligence, or regulatory approvals in states with corporate practice restrictions. FISART manages the timeline by addressing common delay triggers during the preparation phase and running buyer engagement in parallel from day one.

    Most veterinary deals include a post-close employment or consulting agreement for the selling veterinarian, typically ranging from 1-3 years. The length and intensity depend on how clinically dependent the practice is on the owner. If you produce 60%+ of the practice's revenue, buyers will likely require a 2-3 year transition period with production benchmarks. If you have a strong associate team that covers the majority of production, the transition period may be shorter and more flexible. Some owners continue practicing part-time for several years after selling because they enjoy the clinical work without the administrative burden. Others prefer clean exits with shorter transition periods. FISART structures employment terms that protect your compensation, define your clinical role clearly, and include realistic benchmarks that do not put your earnout or retained equity at risk.

    Talk to Us About Your Veterinary Practice

    A confidential initial assessment of your practice structure, associate team, and the buyers active in your segment gives you clarity on your options.

    Schedule a Confidential Consultation